chr15-43234822-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_201631.4(TGM5):āc.1822A>Gā(p.Lys608Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00206 in 1,614,248 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_201631.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGM5 | NM_201631.4 | c.1822A>G | p.Lys608Glu | missense_variant | 11/13 | ENST00000220420.10 | |
TGM5 | NM_004245.4 | c.1576A>G | p.Lys526Glu | missense_variant | 10/12 | ||
TGM5 | XM_011522230.3 | c.793A>G | p.Lys265Glu | missense_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGM5 | ENST00000220420.10 | c.1822A>G | p.Lys608Glu | missense_variant | 11/13 | 1 | NM_201631.4 | P1 | |
TGM5 | ENST00000349114.8 | c.1576A>G | p.Lys526Glu | missense_variant | 10/12 | 1 | |||
TGM5 | ENST00000396996.3 | n.1298A>G | non_coding_transcript_exon_variant | 4/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1733AN: 152244Hom.: 42 Cov.: 32
GnomAD3 exomes AF: 0.00282 AC: 708AN: 251496Hom.: 17 AF XY: 0.00196 AC XY: 267AN XY: 135922
GnomAD4 exome AF: 0.00108 AC: 1584AN: 1461886Hom.: 31 Cov.: 32 AF XY: 0.000960 AC XY: 698AN XY: 727244
GnomAD4 genome AF: 0.0114 AC: 1735AN: 152362Hom.: 43 Cov.: 32 AF XY: 0.0110 AC XY: 822AN XY: 74512
ClinVar
Submissions by phenotype
Acral peeling skin syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at